Pine River Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Pine River Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-461,614	Closed	-$30.3M	–	780
2015 Q4	$30.3M	Buy	461,614 +199,100	+76%	+$12.3M	0.4%	47
2015 Q3	$14.8M	Buy	262,514 +68,288	+35%	+$4.43M	0.19%	112
2015 Q2	$11.5M	Sell	194,226 -190,608	-50%	-$11.8M	0.12%	150
2015 Q1	$24M	Buy	+384,834	New	+$22.4M	0.29%	69
2014 Q3	–	Sell	-76,400	Closed	-$4M	–	1038
2014 Q2	$4M	Buy	76,400 +46,500	+156%	+$2.38M	0.06%	259
2014 Q1	$1.58M	Buy	+29,900	New	+$1.38M	0.02%	404

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pine River Capital Management's TEVA Position: Q1 2016 in Review

Pine River Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 461,614 shares — an estimated $30.3M sold.

Pine River Capital Management first reported a position in TEVA in Q1 2014 and held it in 6 quarters. The position peaked at $30.3M in Q4 2015. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Pine River Capital Management reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Pine River Capital Management sold 461,614 Teva Pharmaceuticals shares in Q1 2016, an estimated $30.3M.
Pine River Capital Management first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 6 quarters.
Pine River Capital Management's Teva Pharmaceuticals position peaked at $30.3M in Q4 2015.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Pine River Capital Management's 13F filing for Q1 2016, filed 16 May 2016.